Today’s AI Top Pick: TMDX

TransMedics is the cleanest multi-timeframe bull setup on the board. All three available timeframes point up: 4h forecasts +63.85%/+44.13%/+42.37% (short/mid/long), 1d +4.36%/+27.93%/+18.90%, and 1wk +2.67%/+9.07%/+21.25%. That's genuine confluence — not a single-timeframe outlier. Kronos bullish_probability is a maxed 1.0 with near_term_bullish at 0.8, the strongest combo in the pool other than MNRO (which has weaker news). Critically, the setup is not stretched. Yes, 4h pos_in_range is 96.93% (extended intraday), but the 1d shows just 33.12% of the 21-bar range with -8.88% drawdown from the high, and the 1wk sits at 62.89% with a -13.66% drawdown. So on the timeframes that matter for a swing trade, TMDX is buying in the middle of a base, not chasing a top. Combine that with fundamentals: 22.69% profit margin, 36.28% ROE, 25.82% sales YoY, PE 22.34, recom 1.75 — a rare 'growth-at-a-reasonable-price' name that has already been beaten down 29% YTD/25% on the year (screen thesis satisfied). The news tape confirms rather than undercuts: on 9/10, TMDX appointed a new CFO AND reiterated 2026 financial outlook — a management confidence signal after a rough tape. The 9/14 Morgan Stanley Global Healthcare presentation is a visibility catalyst. Short float of 24.23% adds squeeze fuel if buyers persist. Contrast with FOUR (strong fwdPe 7.17 but 4h forecasts turn -15% to -24% mid/long), MNDY (pos_in_range 77-79%, near_term_bullish only 0.2), and SMCI (all timeframes negative + fresh IT-controls headline). TMDX is the only name that combines strong fundamentals, unanimous forecast direction, a non-extended daily/weekly entry, top-tier bullish probability, and a positive catalyst. Why today, not later: the 1d is coming off a -8.88% drawdown with forecast turning positive — that's the classic 'buy the flush' point before the tape re-rates toward the +27.93% mid-horizon target. Waiting risks entering after the daily prints back toward the 21-bar high.